Peanut Allergy Therapeutics Industry Research Report 2023
Peanuts are one of the food allergens most commonly associated with anaphylaxis, a sudden and potentially deadly condition that requires immediate attention and treatment.
Highlights
The global Peanut Allergy Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.
The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Peanut Allergy Therapeutics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Peanut Allergy Therapeutics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Peanut Allergy Therapeutics segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Peanut Allergy Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Peanut Allergy Therapeutics market.
Peanut Allergy Therapeutics Segment by Distribution Channel
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Peanut Allergy Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Peanut Allergy Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peanut Allergy Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
Highlights
The global Peanut Allergy Therapeutics market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
United States is the largest consumption place, with a consumption market share nearly 45% in 2019. Following United States, Europe is the second largest consumption place with the consumption market share of 31%.
Market competition is intense. Mylan, Bayer, UCB Pharma, J & J, Perrigo,top 5 players took 52% market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Peanut Allergy Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peanut Allergy Therapeutics.
The Peanut Allergy Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Peanut Allergy Therapeutics market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peanut Allergy Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Mylan
- Bayer
- UCB Pharma
- J & J
- Perrigo
- GSK
- Kaleo
- Amneal Pharma
- ALK Abello
- Aimmune Therapeutics
- HUAPONT Pharm
- Allergy Therapeutics
- ASIT Biotech
- Sanofi
- DBV Technologies
- HAL Allergy
- Intrommune Therapeutics
Global markets are presented by Peanut Allergy Therapeutics type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Peanut Allergy Therapeutics are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Peanut Allergy Therapeutics segment by Type
- Epinephrine Injection
- Antihistamines
- Oral Immunotherapy
- Other
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Peanut Allergy Therapeutics market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Peanut Allergy Therapeutics market.
Peanut Allergy Therapeutics Segment by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Other
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Peanut Allergy Therapeutics market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Peanut Allergy Therapeutics industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Peanut Allergy Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
Frequently Asked Questions
- What factors will challenge the Product Name market growth?
- Which end-use segment will expand at the fastest CAGR in the Product Name market?
- Which are the emerging players in the Product Name market?
- How concentrated is the Product Name market?
- Which factors are positively contributing to the Product Name market growth?
- Which are the novel product innovations in the Product Name market?
- Which product segment will emerge as the most lucrative in the Product Name market?
- Which factors are increasing the competition in the Product Name market?
- Which are the strategic measures taken by the Product Name industry players?
- Which region will witness inactive growth during the forecast period?
- What key trends are likely to emerge in the Product Name market in the coming years?
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Peanut Allergy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2018-2023)
Table 7. Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2024-2029)
Table 9. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Peanut Allergy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Peanut Allergy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Peanut Allergy Therapeutics Market Share by Region (2018-2023)
Table 16. Global Peanut Allergy Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Peanut Allergy Therapeutics Market Share by Region (2024-2029)
Table 18. Peanut Allergy Therapeutics Market Trends
Table 19. Peanut Allergy Therapeutics Market Drivers
Table 20. Peanut Allergy Therapeutics Market Challenges
Table 21. Peanut Allergy Therapeutics Market Restraints
Table 22. Global Top Peanut Allergy Therapeutics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Peanut Allergy Therapeutics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Peanut Allergy Therapeutics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Peanut Allergy Therapeutics, Headquarters and Area Served
Table 26. Global Peanut Allergy Therapeutics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Peanut Allergy Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Mylan Company Detail
Table 46. Mylan Business Overview
Table 47. Mylan Peanut Allergy Therapeutics Product
Table 48. Mylan Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Mylan Recent Development
Table 50. Bayer Company Detail
Table 51. Bayer Business Overview
Table 52. Bayer Peanut Allergy Therapeutics Product
Table 53. Bayer Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. UCB Pharma Company Detail
Table 56. UCB Pharma Business Overview
Table 57. UCB Pharma Peanut Allergy Therapeutics Product
Table 58. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 59. UCB Pharma Recent Development
Table 60. J & J Company Detail
Table 61. J & J Business Overview
Table 62. J & J Peanut Allergy Therapeutics Product
Table 63. J & J Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 64. J & J Recent Development
Table 65. Perrigo Company Detail
Table 66. Perrigo Business Overview
Table 67. Perrigo Peanut Allergy Therapeutics Product
Table 68. Perrigo Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Perrigo Recent Development
Table 70. GSK Company Detail
Table 71. GSK Business Overview
Table 72. GSK Peanut Allergy Therapeutics Product
Table 73. GSK Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 74. GSK Recent Development
Table 75. Kaleo Company Detail
Table 76. Kaleo Business Overview
Table 77. Kaleo Peanut Allergy Therapeutics Product
Table 78. Kaleo Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Kaleo Recent Development
Table 80. Amneal Pharma Company Detail
Table 81. Amneal Pharma Business Overview
Table 82. Amneal Pharma Peanut Allergy Therapeutics Product
Table 83. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Amneal Pharma Recent Development
Table 85. ALK Abello Company Detail
Table 86. ALK Abello Business Overview
Table 87. ALK Abello Peanut Allergy Therapeutics Product
Table 88. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 89. ALK Abello Recent Development
Table 90. Aimmune Therapeutics Company Detail
Table 91. Aimmune Therapeutics Business Overview
Table 92. Aimmune Therapeutics Peanut Allergy Therapeutics Product
Table 93. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Aimmune Therapeutics Recent Development
Table 95. HUAPONT Pharm Company Detail
Table 96. HUAPONT Pharm Business Overview
Table 97. HUAPONT Pharm Peanut Allergy TherapeuticsProduct
Table 98. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 99. HUAPONT Pharm Recent Development
Table 100. Allergy Therapeutics Company Detail
Table 101. Allergy Therapeutics Business Overview
Table 102. Allergy Therapeutics Peanut Allergy TherapeuticsProduct
Table 103. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Allergy Therapeutics Recent Development
Table 105. ASIT Biotech Company Detail
Table 106. ASIT Biotech Business Overview
Table 107. ASIT Biotech Peanut Allergy TherapeuticsProduct
Table 108. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 109. ASIT Biotech Recent Development
Table 110. Sanofi Company Detail
Table 111. Sanofi Business Overview
Table 112. Sanofi Peanut Allergy TherapeuticsProduct
Table 113. Sanofi Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 114. Sanofi Recent Development
Table 115. DBV Technologies Company Detail
Table 116. DBV Technologies Business Overview
Table 117. DBV Technologies Peanut Allergy TherapeuticsProduct
Table 118. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 119. DBV Technologies Recent Development
Table 120. HAL Allergy Company Detail
Table 121. HAL Allergy Business Overview
Table 122. HAL Allergy Peanut Allergy TherapeuticsProduct
Table 123. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 124. HAL Allergy Recent Development
Table 125. Intrommune Therapeutics Company Detail
Table 126. Intrommune Therapeutics Business Overview
Table 127. Intrommune Therapeutics Peanut Allergy TherapeuticsProduct
Table 128. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 129. Intrommune Therapeutics Recent Development
Table 130. Mylan Company Information
Table 131. Mylan Business Overview
Table 132. Mylan Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Mylan Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Mylan Recent Development
Table 135. Bayer Company Information
Table 136. Bayer Business Overview
Table 137. Bayer Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 138. Bayer Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Bayer Recent Development
Table 140. UCB Pharma Company Information
Table 141. UCB Pharma Business Overview
Table 142. UCB Pharma Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 143. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 144. UCB Pharma Recent Development
Table 145. J & J Company Information
Table 146. J & J Business Overview
Table 147. J & J Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 148. J & J Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 149. J & J Recent Development
Table 150. Perrigo Company Information
Table 151. Perrigo Business Overview
Table 152. Perrigo Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 153. Perrigo Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 154. Perrigo Recent Development
Table 155. GSK Company Information
Table 156. GSK Business Overview
Table 157. GSK Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 158. GSK Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 159. GSK Recent Development
Table 160. Kaleo Company Information
Table 161. Kaleo Business Overview
Table 162. Kaleo Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 163. Kaleo Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 164. Kaleo Recent Development
Table 165. Amneal Pharma Company Information
Table 166. Amneal Pharma Business Overview
Table 167. Amneal Pharma Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 168. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 169. Amneal Pharma Recent Development
Table 170. ALK Abello Company Information
Table 171. ALK Abello Business Overview
Table 172. ALK Abello Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 173. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 174. ALK Abello Recent Development
Table 175. Aimmune Therapeutics Company Information
Table 176. Aimmune Therapeutics Business Overview
Table 177. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 178. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 179. Aimmune Therapeutics Recent Development
Table 180. HUAPONT Pharm Company Information
Table 181. HUAPONT Pharm Business Overview
Table 182. HUAPONT Pharm Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 183. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 184. HUAPONT Pharm Recent Development
Table 185. Allergy Therapeutics Company Information
Table 186. Allergy Therapeutics Business Overview
Table 187. Allergy Therapeutics Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 188. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 189. Allergy Therapeutics Recent Development
Table 190. ASIT Biotech Company Information
Table 191. ASIT Biotech Business Overview
Table 192. ASIT Biotech Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 193. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 194. ASIT Biotech Recent Development
Table 195. Sanofi Company Information
Table 196. Sanofi Business Overview
Table 197. Sanofi Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 198. Sanofi Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 199. Sanofi Recent Development
Table 200. DBV Technologies Company Information
Table 201. DBV Technologies Business Overview
Table 202. DBV Technologies Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 203. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 204. DBV Technologies Recent Development
Table 205. HAL Allergy Company Information
Table 206. HAL Allergy Business Overview
Table 207. HAL Allergy Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 208. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 209. HAL Allergy Recent Development
Table 210. Intrommune Therapeutics Company Information
Table 211. Intrommune Therapeutics Business Overview
Table 212. Intrommune Therapeutics Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 213. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 214. Intrommune Therapeutics Recent Development
Table 215. Authors 12. List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Peanut Allergy Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2018-2023)
Table 7. Global Peanut Allergy Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Peanut Allergy Therapeutics Revenue Market Share by Type (2024-2029)
Table 9. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Peanut Allergy Therapeutics Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Peanut Allergy Therapeutics Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Peanut Allergy Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Peanut Allergy Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Peanut Allergy Therapeutics Market Share by Region (2018-2023)
Table 16. Global Peanut Allergy Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Peanut Allergy Therapeutics Market Share by Region (2024-2029)
Table 18. Peanut Allergy Therapeutics Market Trends
Table 19. Peanut Allergy Therapeutics Market Drivers
Table 20. Peanut Allergy Therapeutics Market Challenges
Table 21. Peanut Allergy Therapeutics Market Restraints
Table 22. Global Top Peanut Allergy Therapeutics Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Peanut Allergy Therapeutics Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Peanut Allergy Therapeutics Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Peanut Allergy Therapeutics, Headquarters and Area Served
Table 26. Global Peanut Allergy Therapeutics Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Peanut Allergy Therapeutics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Peanut Allergy Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Peanut Allergy Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. Mylan Company Detail
Table 46. Mylan Business Overview
Table 47. Mylan Peanut Allergy Therapeutics Product
Table 48. Mylan Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 49. Mylan Recent Development
Table 50. Bayer Company Detail
Table 51. Bayer Business Overview
Table 52. Bayer Peanut Allergy Therapeutics Product
Table 53. Bayer Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 54. Bayer Recent Development
Table 55. UCB Pharma Company Detail
Table 56. UCB Pharma Business Overview
Table 57. UCB Pharma Peanut Allergy Therapeutics Product
Table 58. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 59. UCB Pharma Recent Development
Table 60. J & J Company Detail
Table 61. J & J Business Overview
Table 62. J & J Peanut Allergy Therapeutics Product
Table 63. J & J Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 64. J & J Recent Development
Table 65. Perrigo Company Detail
Table 66. Perrigo Business Overview
Table 67. Perrigo Peanut Allergy Therapeutics Product
Table 68. Perrigo Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 69. Perrigo Recent Development
Table 70. GSK Company Detail
Table 71. GSK Business Overview
Table 72. GSK Peanut Allergy Therapeutics Product
Table 73. GSK Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 74. GSK Recent Development
Table 75. Kaleo Company Detail
Table 76. Kaleo Business Overview
Table 77. Kaleo Peanut Allergy Therapeutics Product
Table 78. Kaleo Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 79. Kaleo Recent Development
Table 80. Amneal Pharma Company Detail
Table 81. Amneal Pharma Business Overview
Table 82. Amneal Pharma Peanut Allergy Therapeutics Product
Table 83. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 84. Amneal Pharma Recent Development
Table 85. ALK Abello Company Detail
Table 86. ALK Abello Business Overview
Table 87. ALK Abello Peanut Allergy Therapeutics Product
Table 88. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 89. ALK Abello Recent Development
Table 90. Aimmune Therapeutics Company Detail
Table 91. Aimmune Therapeutics Business Overview
Table 92. Aimmune Therapeutics Peanut Allergy Therapeutics Product
Table 93. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 94. Aimmune Therapeutics Recent Development
Table 95. HUAPONT Pharm Company Detail
Table 96. HUAPONT Pharm Business Overview
Table 97. HUAPONT Pharm Peanut Allergy TherapeuticsProduct
Table 98. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 99. HUAPONT Pharm Recent Development
Table 100. Allergy Therapeutics Company Detail
Table 101. Allergy Therapeutics Business Overview
Table 102. Allergy Therapeutics Peanut Allergy TherapeuticsProduct
Table 103. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 104. Allergy Therapeutics Recent Development
Table 105. ASIT Biotech Company Detail
Table 106. ASIT Biotech Business Overview
Table 107. ASIT Biotech Peanut Allergy TherapeuticsProduct
Table 108. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 109. ASIT Biotech Recent Development
Table 110. Sanofi Company Detail
Table 111. Sanofi Business Overview
Table 112. Sanofi Peanut Allergy TherapeuticsProduct
Table 113. Sanofi Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 114. Sanofi Recent Development
Table 115. DBV Technologies Company Detail
Table 116. DBV Technologies Business Overview
Table 117. DBV Technologies Peanut Allergy TherapeuticsProduct
Table 118. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 119. DBV Technologies Recent Development
Table 120. HAL Allergy Company Detail
Table 121. HAL Allergy Business Overview
Table 122. HAL Allergy Peanut Allergy TherapeuticsProduct
Table 123. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 124. HAL Allergy Recent Development
Table 125. Intrommune Therapeutics Company Detail
Table 126. Intrommune Therapeutics Business Overview
Table 127. Intrommune Therapeutics Peanut Allergy TherapeuticsProduct
Table 128. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2017-2022) & (US$ Million)
Table 129. Intrommune Therapeutics Recent Development
Table 130. Mylan Company Information
Table 131. Mylan Business Overview
Table 132. Mylan Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 133. Mylan Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 134. Mylan Recent Development
Table 135. Bayer Company Information
Table 136. Bayer Business Overview
Table 137. Bayer Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 138. Bayer Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 139. Bayer Recent Development
Table 140. UCB Pharma Company Information
Table 141. UCB Pharma Business Overview
Table 142. UCB Pharma Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 143. UCB Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 144. UCB Pharma Recent Development
Table 145. J & J Company Information
Table 146. J & J Business Overview
Table 147. J & J Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 148. J & J Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 149. J & J Recent Development
Table 150. Perrigo Company Information
Table 151. Perrigo Business Overview
Table 152. Perrigo Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 153. Perrigo Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 154. Perrigo Recent Development
Table 155. GSK Company Information
Table 156. GSK Business Overview
Table 157. GSK Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 158. GSK Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 159. GSK Recent Development
Table 160. Kaleo Company Information
Table 161. Kaleo Business Overview
Table 162. Kaleo Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 163. Kaleo Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 164. Kaleo Recent Development
Table 165. Amneal Pharma Company Information
Table 166. Amneal Pharma Business Overview
Table 167. Amneal Pharma Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 168. Amneal Pharma Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 169. Amneal Pharma Recent Development
Table 170. ALK Abello Company Information
Table 171. ALK Abello Business Overview
Table 172. ALK Abello Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 173. ALK Abello Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 174. ALK Abello Recent Development
Table 175. Aimmune Therapeutics Company Information
Table 176. Aimmune Therapeutics Business Overview
Table 177. Aimmune Therapeutics Peanut Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 178. Aimmune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 179. Aimmune Therapeutics Recent Development
Table 180. HUAPONT Pharm Company Information
Table 181. HUAPONT Pharm Business Overview
Table 182. HUAPONT Pharm Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 183. HUAPONT Pharm Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 184. HUAPONT Pharm Recent Development
Table 185. Allergy Therapeutics Company Information
Table 186. Allergy Therapeutics Business Overview
Table 187. Allergy Therapeutics Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 188. Allergy Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 189. Allergy Therapeutics Recent Development
Table 190. ASIT Biotech Company Information
Table 191. ASIT Biotech Business Overview
Table 192. ASIT Biotech Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 193. ASIT Biotech Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 194. ASIT Biotech Recent Development
Table 195. Sanofi Company Information
Table 196. Sanofi Business Overview
Table 197. Sanofi Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 198. Sanofi Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 199. Sanofi Recent Development
Table 200. DBV Technologies Company Information
Table 201. DBV Technologies Business Overview
Table 202. DBV Technologies Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 203. DBV Technologies Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 204. DBV Technologies Recent Development
Table 205. HAL Allergy Company Information
Table 206. HAL Allergy Business Overview
Table 207. HAL Allergy Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 208. HAL Allergy Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 209. HAL Allergy Recent Development
Table 210. Intrommune Therapeutics Company Information
Table 211. Intrommune Therapeutics Business Overview
Table 212. Intrommune Therapeutics Peanut Allergy TherapeuticsRevenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million)
Table 213. Intrommune Therapeutics Revenue in Peanut Allergy Therapeutics Business (2018-2023) & (US$ Million) Portfolio
Table 214. Intrommune Therapeutics Recent Development
Table 215. Authors 12. List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Peanut Allergy Therapeutics Product Picture
Figure 5. Global Peanut Allergy Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Peanut Allergy Therapeutics Market Share by Type: 2022 VS 2029
Figure 7. Epinephrine Injection Product Picture
Figure 8. Antihistamines Product Picture
Figure 9. Oral Immunotherapy Product Picture
Figure 10. Other Product Picture
Figure 11. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2023-2029) & (US$ Million)
Figure 12. Global Peanut Allergy Therapeutics Market Share by Distribution Channel: 2022 VS 2029
Figure 13. Hospital Pharmacy Product Picture
Figure 14. Retail Pharmacy Product Picture
Figure 15. Other Product Picture
Figure 16. Global Peanut Allergy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Peanut Allergy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Peanut Allergy Therapeutics Market Share by Region: 2022 VS 2029
Figure 19. Global Peanut Allergy Therapeutics Market Share by Players in 2022
Figure 20. Global Peanut Allergy Therapeutics Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Peanut Allergy Therapeutics Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 25. United States Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 29. Germany Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 37. China Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 45. Mexico Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 49. Turkey Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mylan Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 54. UCB Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 55. J & J Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 56. Perrigo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 57. GSK Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 58. Kaleo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 59. Amneal Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 60. ALK Abello Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 61. Aimmune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 62. HUAPONT Pharm Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 63. Allergy Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 64. ASIT Biotech Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 66. DBV Technologies Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 67. HAL Allergy Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 68. Intrommune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Peanut Allergy Therapeutics Product Picture
Figure 5. Global Peanut Allergy Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 6. Global Peanut Allergy Therapeutics Market Share by Type: 2022 VS 2029
Figure 7. Epinephrine Injection Product Picture
Figure 8. Antihistamines Product Picture
Figure 9. Oral Immunotherapy Product Picture
Figure 10. Other Product Picture
Figure 11. Global Peanut Allergy Therapeutics Market Size by Distribution Channel (2023-2029) & (US$ Million)
Figure 12. Global Peanut Allergy Therapeutics Market Share by Distribution Channel: 2022 VS 2029
Figure 13. Hospital Pharmacy Product Picture
Figure 14. Retail Pharmacy Product Picture
Figure 15. Other Product Picture
Figure 16. Global Peanut Allergy Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Peanut Allergy Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Peanut Allergy Therapeutics Market Share by Region: 2022 VS 2029
Figure 19. Global Peanut Allergy Therapeutics Market Share by Players in 2022
Figure 20. Global Peanut Allergy Therapeutics Players, Date of Enter into This Industry
Figure 21. Global Top 5 and 10 Peanut Allergy Therapeutics Players Market Share by Revenue in 2022
Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 23. North America Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. North America Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 25. United States Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Canada Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Europe Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 29. Germany Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Asia-Pacific Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Asia-Pacific Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 37. China Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Japan Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. South Korea Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Southeast Asia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. India Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Australia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Latin America Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Latin America Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 45. Mexico Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Brazil Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Middle East & Africa Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East & Africa Peanut Allergy Therapeutics Market Share by Country (2018-2029)
Figure 49. Turkey Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Saudi Arabia Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. UAE Peanut Allergy Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Mylan Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 53. Bayer Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 54. UCB Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 55. J & J Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 56. Perrigo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 57. GSK Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 58. Kaleo Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 59. Amneal Pharma Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 60. ALK Abello Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 61. Aimmune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 62. HUAPONT Pharm Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 63. Allergy Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 64. ASIT Biotech Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 65. Sanofi Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 66. DBV Technologies Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 67. HAL Allergy Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
Figure 68. Intrommune Therapeutics Revenue Growth Rate in Peanut Allergy Therapeutics Business (2018-2023)
